Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

NCT00103207 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

NETWORK

Sponsor class

Conditions

Lung Cancer

Interventions

BIOLOGICAL: cetuximab

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]